Interesting aspects concerning the safety of SILICIUM products
SILICIUM products are manufactured to more stringent pharmaceutical quality standards than those of a food manufacturing plant or food supplement. Since 2005, Silicium manufactures the authentic formula of Doctor in Sciences Loïc Le Ribault, creator of the product protected for years by the patent: "Therapeutic composition comprising organo-silicic compounds", number FR8519204A. The company Silicium continues to conduct dozens of studies and actions to improve the quality of its products: Efficacy Studies Our preclinical studies on cells have shown that the presence of silicon in the precursor cells of the bone increases collagen synthesis and promotes its mineralization.
Non-toxicity studies conducted in the United States, which, although not mandatory, strengthen the evidence on the safety of our products and ensure the safety of our ingredients: OCDE 471, AMES Bacterial Reverse Mutation study; OCDE 473, Chromosome Aberration; OCDE 474, Mouse Micronucleus; OCDE 407, 14 days Repeated oral toxicity 14 days; OECD 408, 90 days of Repeated oral toxicity. All these studies prove the non-toxicity of the product , its inability to produce aberrations or genetic mutations, or to cause cancer.
Stability studies To ensure the quality and safety of products throughout their shelf life..
Eliminating preservatives We are a healthy lifestyle company, and we use different preservation processes that are more respectful to the body. SILICON LABORATORIES after several years of research has succeeded in eliminating preservatives, treating products with new natural processes.
Guarantee of quality All batches of our products are analyzed, to guarantee the quality and the safety of our products. From the absence of pathogenic or harmful microorganisms, we evaluate physicochemical parameters such as pH and density, as well as silicon content, monomethylsilanetriol and silicic acid by nuclear magnetic resonance (NMR) analysis and chromatography.
Patents: We have international patents that protect SILICIUM's new developments in the field of solid and powdered silanols with high bioavailability: "ORGANOSILICON COMPOUND MICROPARTICLES AND PROCESS FOR THEIR PREPARATION" No. PCT / EP2019 / 055401
We work to provide you with the most effective solution for your wellbeing
Dr. N. Boqué
EURECAT /TECHNOLOGICAL CENTER OF CATALONIA
Spain - 2015
a single comparative dose was administered,
to evaluate the absorption of silicon from each food supplement.
Between 2 and 100 times more assimilable
than competing products
Dr. M. Trila
Spain - 2017
liquid and solid products is quantified as part of the quality assurance process.
most assimilable form. in a high proportion in the most assimilable form.
In vitro bioavailability
Brazil - 2019
by inductively coupled plasma mass spectrophotometry (ICP-MS),
and quantified the content of soluble silicon in aqueous medium.
soluble silicon compared to other samples on the market.
For more detailed information, contact us at: +34 877 44 99 48 or send us your email to: info@siliciumG5.com.